Holen Sie sich die Stockscreener-App
187.38
17.88%
28.42
Handel nachbörslich:
189.00
1.62
+0.86%
Schlusskurs vom Vortag:
$158.96
Offen:
$171.33
24-Stunden-Volumen:
6.85M
Relative Volume:
2.96
Marktkapitalisierung:
$32.42B
Einnahmen:
$15.50B
Nettoeinkommen (Verlust:
$1.33B
KGV:
25.53
EPS:
7.34
Netto-Cashflow:
$2.16B
1W Leistung:
+18.84%
1M Leistung:
+21.10%
6M Leistung:
-8.78%
1J Leistung:
-23.59%
1-Tages-Spanne:
$170.16
$190.13
1-Wochen-Bereich:
$156.16
$190.13
52-Wochen-Spanne:
$134.65
$252.88
Iqvia Holdings Inc Stock (IQV) Company Profile
Firmenname
Iqvia Holdings Inc
Sektor
Branche
Telefon
919-998-2000
Adresse
2400 ELLIS ROAD, DURHAM, NC
Vergleichen Sie IQV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IQV
Iqvia Holdings Inc
|
187.38 | 27.28B | 15.50B | 1.33B | 2.16B | 7.34 |
|
TMO
Thermo Fisher Scientific Inc
|
427.62 | 157.79B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
189.91 | 138.02B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
532.00 | 42.36B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
116.19 | 32.08B | 6.63B | 1.17B | 1.19B | 4.05 |
Iqvia Holdings Inc Stock (IQV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-25 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-04-10 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-02-03 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-12-20 | Eingeleitet | Stephens | Overweight |
| 2024-10-14 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-09-04 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-07-24 | Herabstufung | Jefferies | Buy → Hold |
| 2024-06-06 | Eingeleitet | Goldman | Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-02-15 | Herabstufung | Guggenheim | Buy → Neutral |
| 2024-02-13 | Eingeleitet | BTIG Research | Buy |
| 2023-11-02 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2023-09-06 | Eingeleitet | HSBC Securities | Buy |
| 2023-03-17 | Eingeleitet | Truist | Buy |
| 2022-12-06 | Eingeleitet | Cowen | Outperform |
| 2022-11-17 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-07-15 | Eingeleitet | SVB Leerink | Outperform |
| 2022-05-24 | Eingeleitet | Guggenheim | Buy |
| 2022-04-29 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-04-16 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2021-03-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2020-07-07 | Eingeleitet | Stephens | Equal-Weight |
| 2020-03-02 | Eingeleitet | Deutsche Bank | Buy |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-12-13 | Hochstufung | CFRA | Sell → Hold |
| 2019-11-14 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2019-06-21 | Hochstufung | Mizuho | Neutral → Buy |
| 2019-05-28 | Eingeleitet | SVB Leerink | Outperform |
| 2019-01-18 | Hochstufung | Jefferies | Hold → Buy |
| 2018-10-09 | Eingeleitet | UBS | Buy |
| 2018-10-02 | Bestätigt | Robert W. Baird | Outperform |
| 2018-07-25 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2018-07-25 | Bestätigt | Stifel | Buy |
| 2018-07-03 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2018-04-13 | Hochstufung | Goldman | Neutral → Buy |
| 2018-03-07 | Hochstufung | SunTrust | Hold → Buy |
| 2018-01-19 | Eingeleitet | Evercore ISI | Outperform |
Alle ansehen
Iqvia Holdings Inc Aktie (IQV) Neueste Nachrichten
IQVIA Holdings Reports Strong Q2 2025 Results - TipRanks
IQVIA Q2 2025 Earnings Call Transcript - MarketBeat
IQVIA Stock: Decoding Recent Market Moves - timothysykes.com
IQVIA's Trading Volume Surges 243% to 12.8 Billion, Ranked 67th in Market Activity - AInvest
What drives IQVIA Holdings Inc. stock priceExceptional market performance - Autocar Professional
IQVIA's Q2 Earnings Beat and AI-Driven Growth: Strategic AI Adoption Fuels Resilience in a Volatile Biopharma Market - AInvest
IQVIA: Q2 Earnings Exceeded My Expectations (NYSE:IQV) - Seeking Alpha
Evercore ISI raises IQVIA stock price target to $220 on improved pharma demand - Investing.com Nigeria
IQVIA HOLDINGS INC. SEC 10-Q Report - TradingView
IQVIA Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
IQVIA leads S&P 500 on strong Q2 earnings, better-than-expected guidance - Sherwood News
U.S. Indexes Finished Mixed Tuesday As IQVIA Holdings Led, Lockheed Martin Lagged - Barron's
What analysts say about IQVIA Holdings Inc. stockHigh-octane investment gains - jammulinksnews.com
IQVIA (IQV) Surpasses Revenue Expectations with Strong Q2 Perfor - GuruFocus
IQVIA Leads S&P 500 Gainers on Better-Than-Expected Earnings - Yahoo Finance
IQVIA: Is It Time to Buy After Recent Price Drop? - timothysykes.com
The CRO Sector's Quiet Revolution: How Medpace and IQVIA Are Leading the Charge - AInvest
IQVIA Holdings (IQV) Updates 2025 Revenue Guidance and Completes Share Buyback - Yahoo Finance
IQVIA: Q2 Earnings Snapshot - CTPost
IQVIA Holdings Inc. Exceeds Q2 Earnings Expectations with $266 Million Net IncomeNews and Statistics - IndexBox
Top Stock Movers Now: GM, Lockheed Martin, IQVIA, DR Horton, and More - 富途牛牛
IQVIA Earnings & Revenues Beat Estimates in Q2, Rise Y/Y - TradingView
Price Target Raised for IQVIA Amid Positive Market Outlook - StocksToTrade
Why IQVIA (IQV) Stock Is Trading Up Today - Yahoo Finance
Evercore Raises IQVIA’s Price Target Amid Market Optimism - timothysykes.com
IQVIA's AI-Driven Growth and Segment Performance in Q2 2025: A Blueprint for Long-Term Healthcare Tech Investment - AInvest
Earnings call transcript: IQVIA Q2 2025 beats expectations, stock surges By Investing.com - Investing.com Nigeria
Earnings call transcript: IQVIA Q2 2025 beats expectations, stock surges - Investing.com India
D.R. Horton, IQVIA Holdings, Northrop Grumman And Other Big Stocks Moving Higher On Tuesday - inkl
IQVIA Q2 2025 slides: revenue up 5.3%, AI innovation drives growth - Investing.com
IQV Stock Soars Over 16% Boosting Investor Confidence | IQV Stoc - GuruFocus
IQVIA (IQV) Soars After Strong Q2 2025 Earnings - GuruFocus
IQVIA Holdings Beats Forecasts, But Outlook Tightens - Finimize
IQVIA's Resilient Growth in Q2 2025: A Strategic Bet on the Future of Healthcare Data and Life Sciences - AInvest
IQVIA Holdings Inc reports results for the quarter ended June 30Earnings Summary - TradingView
IQVIA shares soar as Q2 results top estimates, outlook strong - Investing.com Australia
Iqvia stock, Medpace stock up after Q2 beats (IQV:NYSE) - Seeking Alpha
IQVIA beats quarterly estimates on resilient demand for healthcare analytics - TradingView
IQVIA Holdings (IQV) Q2 Earnings and Revenues Surpass Estimates - Yahoo Finance
IQVIA Holdings Inc. Updates Earnings Guidance for the Full Year 2025 - MarketScreener
D.R. Horton, Medpace, IQVIA - TradingView
IQVIA Holdings Inc Reports Q2 2025 Revenue of $4.017 Billion, Be - GuruFocus
IQVIA (NYSE:IQV) Beats Q2 Sales Targets, Stock Soars - Yahoo Finance
S&P 500 Futures Decline in Premarket Trading; Medpace Holdings, IQVIA Holdings Lead - Barron's
IQVIA Reports Second-Quarter 2025 Results - TradingView
(IQV) IQVIA Expects Full Year 2025 Revenue Range $16.10B$16.30B, vs. FactSet Est of $16.06B - MarketScreener
IQVIA Holdings earnings beat by $0.04, revenue topped estimates - Investing.com Canada
IQVIA Q2 revenue up 5.3% YoY to $4,017mln, R&D Solutions bookings reach $2.5bln. - AInvest
IQVIA Delivers $4B Quarter: Strong TAS Growth, $32.1B Backlog, and Beats Profit Expectations - Stock Titan
IQVIA Holdings Inc. Stock Analysis and ForecastOver 200% growth - jammulinksnews.com
IQVIA Holdings Inc. Earnings Report: Projections and InsightsNews and Statistics - IndexBox
Finanzdaten der Iqvia Holdings Inc-Aktie (IQV)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.70%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):